Arrowhead Research | ARWR - Eps Utile Per Azione


Fiscal Calendario Efettivo Consenso Precedente Data
FY2026Q4 Sep/2025 -1.12 -0.11 Nov/30
FY2026Q3 Jun/2026 -1.36 -1.20 -1.26 Aug/04
FY2026Q2 Mar/2026 -0.93 -1.04 2.75 May/07
FY2026Q1 Dec/2025 0.22 0.04 -1.39 Feb/05
FY2025Q4 Sep/2025 -0.11 -0.23 -1.36 Nov/25




Eps Cambiamento Data
Agios Pharmaceuticals USD -1.69 0 2026-06
Alnylam Pharmaceuticals USD 1.84 0.15 2026-06
Anika Therapeutics USD 0.13 0.35 2025-12
Arrowhead Research USD -1.36 0.43 2026-06
Heron Therapeutics USD -0.02 0.02 2025-12
Incyte USD 3.09 1.28 2026-06
Ionis Pharmaceuticals USD -0.69 0.13 2026-06
Ligand Pharmaceuticals USD 2.37 0.74 2026-06
Merck USD -0.13 1.15 2026-06
Moderna USD -1.97 1.43 2026-06
Nektar Therapeutics USD -1.78 0.43 2026-03
Novartis USD 2.41 0.42 2026-06
Sarepta Therapeutics USD 0.64 2.52 2026-06
TG Therapeutics USD 0.05 0.07 2026-06
Ultragenyx Pharmaceutical USD -0.9 0.94 2026-06
Vertex Pharmaceuticals USD 4.73 0.26 2026-06
Xencor USD -0.29 1.42 2026-06